Quest Diagnostics (DGX) News Today

Quest Diagnostics Incorporated (NYSE:DGX - Get Free Report) SVP Mark E. Delaney sold 420 shares of Quest Diagnostics stock in a transaction on Wednesday, July 24th. The stock was sold at an average price of $143.08, for a total value of $60,093.60. Following the sale, the senior vice president now directly owns 5,019 shares of the company's stock, valued at approximately $718,118.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Natixis lessened its holdings in Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 46.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 19,883 shares of the medical research company's stock after sell

Quest Diagnostics Incorporated (NYSE:DGX - Free Report) - Equities research analysts at William Blair increased their Q4 2024 EPS estimates for Quest Diagnostics in a research note issued to investors on Tuesday, July 23rd. William Blair analyst A. Brackmann now forecasts that the medical researc

Quest Diagnostics Incorporated (NYSE:DGX - Free Report) - Analysts at Leerink Partnrs raised their FY2024 earnings per share (EPS) estimates for Quest Diagnostics in a research report issued to clients and investors on Tuesday, July 23rd. Leerink Partnrs analyst M. Cherny now forecasts that the m

CANADA LIFE ASSURANCE Co boosted its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 3.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 406,643 shares of the medical resea

Robert W. Baird increased their target price on Quest Diagnostics from $153.00 to $154.00 and gave the company a "neutral" rating in a report on Wednesday.

Seven Eight Capital LP purchased a new position in Quest Diagnostics Incorporated (NYSE:DGX - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 5,474 shares of the medical research compa

Quest Diagnostics (NYSE:DGX) Trading Down 4.8%

Quest Diagnostics (NYSE:DGX) updated its FY24 earnings guidance. The company provided EPS guidance of $8.80-9.00 for the period, compared to the consensus estimate of $8.85. The company also issued revenue guidance of $9.50-9.58 billionillion, compared to the consensus estimate of $9.46 billionillion.

StockNews.com raised Quest Diagnostics from a "hold" rating to a "buy" rating in a research note on Tuesday.

Vanguard Group Inc. lifted its holdings in Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 2.5% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 13,921,955 shares of the medical research company's stock after buying an additional 3

Mitsubishi UFJ Trust & Banking Corp lowered its position in shares of Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 10.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 167,167 shares of the medic

M&G Plc purchased a new position in shares of Quest Diagnostics Incorporated (NYSE:DGX - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 349,116 shares of the medical research company's stock, valued at a

Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 16.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 131,329 shares of the medical research company's stock

State Board of Administration of Florida Retirement System grew its position in shares of Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 13.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15

Motley Fool Asset Management LLC lifted its holdings in Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 278.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,892 shares of the medical research com

Thoroughbred Financial Services LLC lowered its holdings in Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 31.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,584 shares of the medical resear

Quest Diagnostics Incorporated (NYSE:DGX - Free Report) - Analysts at Leerink Partnrs increased their FY2025 EPS estimates for Quest Diagnostics in a research report issued to clients and investors on Monday, July 15th. Leerink Partnrs analyst M. Cherny now forecasts that the medical research com

Quest Diagnostics (NYSE:DGX) will be releasing earnings before the market opens on Tuesday, July 23, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=316235)

Sei Investments Co. increased its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 13.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 279,105 shares of the medical research compan

Truist Financial boosted their price objective on shares of Quest Diagnostics from $150.00 to $158.00 and gave the stock a "hold" rating in a research report on Monday.

SG Americas Securities LLC grew its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 1,077.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 109,802 shares of the medical research

Quantbot Technologies LP acquired a new position in Quest Diagnostics Incorporated (NYSE:DGX - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 15,955 shares of the medical resea

StockNews.com upgraded shares of Quest Diagnostics from a "hold" rating to a "buy" rating in a research report on Wednesday.

FORA Capital LLC lifted its position in shares of Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 31.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,703 shares of the medical research company's stoc